Key Findings

  • No deviation or variation in utilization of proceeds from preferential allotment during quarter ended September 30, 2026
  • Monitoring agency: Not applicable
  • Shareholder approval: Not applicable (no deviation)
  • Explanation for deviation: Not applicable
  • Audit Committee comments: NIL
  • Auditor comments: NIL

Fund Raising Details

  • Mode of Fund Raising: Preferential Allotment
  • Type of Instrument: Equity
  • Date of Raising Funds: January 2, 2026
  • Amount Raised: ₹30.74 crore (3074 Lakhs)

Fund Utilization Breakdown (as of September 30, 2026)

1. Capital Expenditure

  • Original Allocation: ₹5.00 crore (500 Lakhs)
  • Funds Utilized: ₹4.14 crore (414.46 Lakhs)
  • Deviation/Variation: NA

2. Working Capital Requirement

  • Original Allocation: ₹3.50 crore (350 Lakhs)
  • Funds Utilized: ₹2.80 crore (279.97 Lakhs)
  • Deviation/Variation: NA

3. Working Capital & Capital Expenditure for Subsidiary

  • Original Allocation: ₹5.00 crore (500 Lakhs)
  • Funds Utilized: ₹3.01 crore (300.53 Lakhs)
  • Deviation/Variation: NA

4. Acquisition of API/Formulation unit(s)

  • Original Allocation: ₹10.00 crore (1000 Lakhs)
  • Funds Utilized: ₹3.00 crore (300.00 Lakhs)
  • Deviation/Variation: NA

5. Corporate General Purposes

  • Original Allocation: ₹7.24 crore (724 Lakhs)
  • Funds Utilized: ₹1.89 crore (189.04 Lakhs)
  • Deviation/Variation: NA

Compliance Details

  • Digital signature date: November 11, 2026 at 18:08:11 IST
  • Filing submitted to: BSE Limited